PUBLIC CONTRACT · 2024
Aquisição de Andexanet alfa 200 mg Pó para solução para perfusão
- Contract value
- €25,600.00
- Signed on
- 1 August 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11040238PUBLISHED SUBJECT
Aquisição de Andexanet alfa 200 mg Pó para solução para perfusão
Parties involved
- Place of performance
- Portugal, Braga, Braga
- NUTS region
- PT112 - Cávado
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AstraZeneca - Produtos Farmacêuticos, Lda. · Tax ID 502942240
Values and timeline
- Contract price
- €25,600.00
- Procedure base price
- €25,600.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 22 November 2024
- Award date
- 30 July 2024
- Signing date
- 1 August 2024
- Performance period
- 151 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7152122
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.